Clarivate PLC CLVT 深 沪
已收盘 02-06 16:00:00 美东时间
2.16
+0.080
+3.85%
华盛通- 最 高2.20
- 今 开2.08
- 成交量 1108.04万股
- 最 低 2.02
- 昨 收 2.08
- 总市值 14.29亿
- 52周最高 5.155
- 市盈率 静 --
- 换手率 1.68%
- 52周最低 1.94
- 委 比 -8.18%
- 总股本 6.61亿
- 历史最高 34.79
- 量 比 1.16
- 振 幅 8.65%
- 历史最低 1.94
- 每 手 1
- 风险率 0.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Stocks Fall, Gold Rallies On Best Day Since 2008: What's Moving Markets Tuesday?
Wall Street extended losses into midday trading Tuesday as geopolitical tensions in the Middle East resurfaced, while gold staged a violent rebound after two days of historic selling.
02-04 02:18
Clarivate redeems notes, advances capital allocation strategy
Clarivate ( ($CLVT) ) has shared an update. On January 30, 2026, Clarivate’s su...
02-02 20:58
Clarivate Subsidiary Reeems Remaining $100M, 4.50% Senior Notes Due 2026
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that its subsidiary, Camelot Finance S.A., has redeemed the remaining $100 million aggregate principal amount of its
02-02 20:33
Top 3 Industrials Stocks You'll Regret Missing This Quarter
The most oversold stocks in the industrials sector presents an opportunity to b...
01-22 19:25
Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources
Clarivate Nexus integrates academic content and services into the AI tools increasingly used by students and researchers, helping libraries and institutions remain central to trusted scholar...
01-22 16:00
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year
Royal Philips has been named a Clarivate Top 100 Global Innovator for 2026 for the 13th consecutive year, highlighted as the highest-ranking medical technology company. The company invests over €1.7 billion annually in R&D, around 9% of its sales, to drive innovations that enhance healthcare delivery and consumer health. Key innovations include the Philips Verida spectral CT system, helium-free MRI magnets, and advanced consumer health solutions.
01-21 10:00
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Goldman Sachs Downgrades Clarivate to Neutral, Lowers Price Target to $3.6
Goldman Sachs analyst George Tong downgrades Clarivate (NYSE:CLVT) from Buy to Neutral and lowers the price target from $4.2 to $3.6.
01-09 01:38
Clarivate unveils 2026 Drugs to Watch highlighting 11 promising therapies
Clarivate (CLVT) on Tuesday released its 2026 Drugs to Watch report, highlighting 11 therapies expected to deliver meaningful clinical benefits and strong commercial potential in the year ahead. The a...
01-06 16:16
S&P 500 Hits All-Time Highs On Christmas Eve, VIX Drops To One-Year Low: What's Moving Markets Wednesday?
Wall Street delivered the kind of Christmas present investors had been hoping for, as the S&P 500 set fresh records while a key measure of market anxiety fell to its lowest level in more than a year.
2025-12-25 00:35
